Remove 2008 Remove Anaphylaxis Remove Outcomes
article thumbnail

Review of the ATHOS 3 trial

Northwestern EM Blog

The primary outcome of the study was the response in MAP three hours after the start of angiotensin II infusion. It showed improvement in blood pressure which is a clinically important parameter but not a patient-oriented outcome. NEJM 2008; 358(9): 877 – 87. Crit Care 2014; 18(5): 534. PMID: 25286986 Russell JA et al.

Shock 52
article thumbnail

REBEL Core Cast 122.0 – Neutropenic Fever

RebelEM

2008 Sep;1138:329-50. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Time to antibiotics and outcomes in cancer patients with febrile neutropenia. Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. 2016.11.007.